Preferred Label : proprotein convertases;

MeSH definition : Proteolytic enzymes that are involved in the conversion of protein precursors such as peptide prohormones into PEPTIDE HORMONES. Some are ENDOPEPTIDASES, some are EXOPEPTIDASES.;

MeSH synonym : convertase, proprotein; convertases, proprotein; proprotein convertase;

DeCS synonym : Proprotein Convertases, Subtilisin-Kexin Family;

MeSH hyponym : Subtilisin-Like proprotein convertases; prohormone convertases; Pro-Opiomelanocortin converting enzyme; Convertases, Prohormone; Prohormone Convertase; Convertase, Prohormone; Proprotein Convertases, Subtilisin Kexin Family; Proprotein Convertase, Subtilisin-Kexin Family; Proprotein Convertase, Subtilisin Kexin Family; Convertases, Subtilisin-Like Proprotein; Proprotein Convertases, Subtilisin-Like; Subtilisin Like Proprotein Convertases; Converting Enzyme, Pro-Opiomelanocortin; Pro Opiomelanocortin Converting Enzyme; POMC Enzyme; POMC-Converting Enzyme; POMC Converting Enzyme; Pro-Opiocortin Converting Protease; Converting Protease, Pro-Opiocortin; Pro Opiocortin Converting Protease; Proopiomelanocortin Convertase; Convertase, Proopiomelanocortin; POMC Convertase; Convertase, POMC; Pro-Opiocortin Converting Enzyme; Converting Enzyme, Pro-Opiocortin; Pro Opiocortin Converting Enzyme;

CISMeF hyponym : EC 3.4.-;

MeSH Related Number : prohormone convertases; Pro-Opiomelanocortin converting enzyme; Subtilisin-Like proprotein convertases; EC 3.4.-; EC 3.4.23.17; EC 3.4.21.-; EC 3.4.21.61;

Registry Number MeSH : EC 3.4.-; EC 3.4.21.-;

Related CAS MeSH : EC 3.4.- (Prohormone convertases); EC 3.4.- (Subtilisin-Like proprotein convertases); EC 3.4.23.17 (Pro-Opiomelanocortin converting enzyme);

Wikipedia link : https://en.wikipedia.org/wiki/Pro-opiomelanocortin converting enzyme;

Is substance : O;

Details


Main resources

You can consult :

Proteolytic enzymes that are involved in the conversion of protein precursors such as peptide prohormones into PEPTIDE HORMONES. Some are ENDOPEPTIDASES, some are EXOPEPTIDASES.

https://www.revmed.ch/RMS/2017/RMS-N-558/Inhibiteurs-de-la-PCSK9
2017
false
false
false
Switzerland
French
journal article
Proprotein Convertase 9
Proprotein Convertase 9
anticholesteremic agents
anticholesteremic agents
cardiovascular diseases
risk factors
cholesterol, LDL
At increased risk for cardiovascular event (finding)
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
Proprotein Convertase 9
mutation
alirocumab
evolocumab
PCSK9 protein, human
bococizumab
comparative effectiveness research
high serum cholesterol, familial
antibodies, monoclonal
serine endopeptidases
proprotein convertases
antibodies, monoclonal, humanized
hyperlipoproteinemia type ii

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.